36 studies found for:    " July 01, 2009":" July 31, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix
Conditions: Herpes Simplex Type Two Infection;   HIV Infections
Interventions: Drug: Valacyclovir;   Drug: Placebo
22 Completed IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
Interventions: Drug: Isentress®;   Drug: Celsentri®
23 Completed Effect of Antacids on the Pharmacokinetics of Raltegravir
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: antacid
24 Unknown  Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
25 Completed
Has Results
A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)
Conditions: HIV Infections;   Hepatitis C;   HCV Infection
Interventions: Drug: PegIFN-2b;   Drug: RBV;   Drug: Placebo to Boceprevir;   Drug: Boceprevir
26 Unknown  Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs)
Condition: HIV Infections
Intervention: Drug: Adaptavir (monomeric DAPTA)
27 Completed Improving Latent Tuberculosis (TB) Diagnosis in Thai Children
Conditions: Latent Tuberculosis;   HIV Infections
28 Unknown  Patient Preference, Sleep Quality, and Anxiety/Depression: A Comparison of Raltegravir and Efavirenz
Conditions: Sleep Disorders;   HIV Infections
Interventions: Drug: Raltegravir for the first 2 weeks;   Drug: Efavirenz for the last 2 weeks;   Drug: Efavirenz for the first 2 weeks;   Drug: Raltegravir for the last 2 weeks
29 Unknown  Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Conditions: Cervical Cancer Screening;   HIV Infections
30 Completed
Has Results
Evaluation of Diagnostic HIV Ag/Ab Combo Assay
Condition: Human Immunodeficiency Viruses
Intervention: Device: ARCHITECT HIV Ag/Ab Combo
31 Unknown  Simplification From Protease Inhibitors to Raltegravir
Condition: HIV Infections
Intervention: Drug: Raltegravir (Use RAL as a simplification strategy)
32 Terminated Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Conditions: HIV1 Infection;   HIV Infections
33 No longer available An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
Condition: HIV Infections
Intervention: Drug: Tipranavir
34 Completed
Has Results
A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Condition: HIV Infections
Interventions: Drug: raltegravir;   Drug: 2N(t)RTI;   Drug: Ritonavir-boosted lopinavir
35 Completed GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study
Condition: Healthy Volunteer
Interventions: Drug: GSK1349572;   Drug: Placebo;   Drug: Omeprazole
36 Completed The Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Lersivirine;   Drug: Placebo;   Drug: Lersivirine (if necessary);   Drug: Moxifloxacin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years